Suzetrigine
VX24-548-111
Phase 3 small_molecule active
Quick answer
Suzetrigine for Diabetic Peripheral Neuropathic Pain is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 3 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Diabetic Peripheral Neuropathic Pain
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active